Beta Bionics Common Stock Price Patterns

BBNX Stock   14.73  0.06  0.41%   
The relative strength index (RSI) of Beta Bionics' share price is below 30 at this time suggesting that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Beta Bionics Common, making its price go up or down.

Momentum 25

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Beta Bionics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Beta Bionics Common, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Beta Bionics' stock price prediction:
EPS Estimate Current Year
(1.89)
EPS Estimate Next Year
(1.71)
Wall Street Target Price
30.4546
Quarterly Revenue Growth
0.631
Using Beta Bionics hype-based prediction, you can estimate the value of Beta Bionics Common from the perspective of Beta Bionics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Beta Bionics using Beta Bionics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Beta using crowd psychology based on the activity and movement of Beta Bionics' stock price.

Beta Bionics Short Interest

An investor who is long Beta Bionics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Beta Bionics and may potentially protect profits, hedge Beta Bionics with its derivative instruments, or be ready for some potential downside.
200 Day MA
19.9966
Short Percent
0.1421
Short Ratio
3.67
Shares Short Prior Month
7.3 M
50 Day MA
26.5711

Beta Bionics Common Hype to Price Pattern

Investor biases related to Beta Bionics' public news can be used to forecast risks associated with an investment in Beta. The trend in average sentiment can be used to explain how an investor holding Beta can time the market purely based on public headlines and social activities around Beta Bionics Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Beta Bionics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Beta Bionics.

Beta Bionics Implied Volatility

    
  1.52  
Beta Bionics' implied volatility exposes the market's sentiment of Beta Bionics Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Beta Bionics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Beta Bionics stock will not fluctuate a lot when Beta Bionics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Beta Bionics to buy its stock at a price that has no basis in reality. In that case, they are not buying Beta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Beta Bionics after-hype prediction price

    
  USD 16.08  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Beta contract

Based on the Rule 16, the options market is currently suggesting that Beta Bionics Common will have an average daily up or down price movement of about 0.095% per day over the life of the 2026-04-17 option contract. With Beta Bionics trading at USD 14.73, that is roughly USD 0.014 . If you think that the market is fully incorporating Beta Bionics' daily price movement you should consider acquiring Beta Bionics Common options at the current volatility level of 1.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Beta Bionics Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
12.3418.5124.68
Details
Naive
Forecast
LowNextHigh
10.0116.1822.36
Details
7 Analysts
Consensus
LowTargetHigh
27.7130.4533.80
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.52-0.47-0.41
Details

Beta Bionics After-Hype Price Density Analysis

As far as predicting the price of Beta Bionics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Beta Bionics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Beta Bionics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Beta Bionics Estimiated After-Hype Price Volatility

In the context of predicting Beta Bionics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Beta Bionics' historical news coverage. Beta Bionics' after-hype downside and upside margins for the prediction period are 9.91 and 22.25, respectively. We have considered Beta Bionics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
14.73
16.08
After-hype Price
22.25
Upside
Beta Bionics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Beta Bionics Common is based on 3 months time horizon.

Beta Bionics Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Beta Bionics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Beta Bionics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Beta Bionics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.81 
6.17
  1.35 
  0.14 
14 Events / Month
7 Events / Month
In about 14 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
14.73
16.08
9.16 
369.46  
Notes

Beta Bionics Hype Timeline

Beta Bionics Common is currently traded for 14.73. The entity has historical hype elasticity of 1.35, and average elasticity to hype of competition of 0.14. Beta is estimated to increase in value after the next headline, with the price projected to jump to 16.08 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 9.16%, whereas the daily expected return is currently at -0.81%. The volatility of related hype on Beta Bionics is about 3694.61%, with the expected price after the next announcement by competition of 14.87. The company has return on total asset (ROA) of (0.2008) % which means that it has lost $0.2008 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4752) %, meaning that it created substantial loss on money invested by shareholders. Beta Bionics' management efficiency ratios could be used to measure how well Beta Bionics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.35 in 2026. Return On Capital Employed is likely to drop to -0.33 in 2026. At this time, Beta Bionics' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 4.9 M in 2026, whereas Total Assets are likely to drop slightly above 108.2 M in 2026. Given the investment horizon of 90 days the next estimated press release will be in about 14 days.
Check out Beta Bionics Basic Forecasting Models to cross-verify your projections.

Beta Bionics Related Hype Analysis

Having access to credible news sources related to Beta Bionics' direct competition is more important than ever and may enhance your ability to predict Beta Bionics' future price movements. Getting to know how Beta Bionics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Beta Bionics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
STAASTAAR Surgical 2.29 11 per month 0.00 (0.16) 5.26 (5.66) 15.08 
TRMLTourmaline Bio 0.01 4 per month 0.00  0.17  6.53 (2.70) 58.54 
PLSEPulse Biosciences(0.15)11 per month 0.00 (0.16) 3.83 (4.51) 14.41 
TERNTerns Pharmaceuticals(0.32)11 per month 2.22  0.25  13.30 (5.57) 76.18 
PGENPrecigen 0.30 9 per month 4.59  0.03  6.97 (7.08) 38.64 
IMTXImmatics NV(0.13)7 per month 0.00 (0.02) 7.31 (6.47) 30.34 
KMTSKestra Medical Technologies(0.50)10 per month 0.00 (0.02) 4.59 (7.02) 20.54 
DVAXDynavax Technologies 0.03 14 per month 0.67  0.13  2.76 (1.53) 39.08 
ORICOric Pharmaceuticals(0.07)9 per month 0.00 (0.05) 6.63 (4.48) 15.34 
AHCOAdapthealth Corp 0.21 6 per month 2.20  0.02  4.17 (3.28) 24.44 

Beta Bionics Additional Predictive Modules

Most predictive techniques to examine Beta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Beta using various technical indicators. When you analyze Beta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Beta Bionics Predictive Indicators

The successful prediction of Beta Bionics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Beta Bionics Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Beta Bionics based on analysis of Beta Bionics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Beta Bionics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Beta Bionics's related companies.
 2024 2025 2026 (projected)
Days Sales Outstanding67.2377.32111.42
PTB Ratio1.982.282.16

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Beta Stock Analysis

When running Beta Bionics' price analysis, check to measure Beta Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Bionics is operating at the current time. Most of Beta Bionics' value examination focuses on studying past and present price action to predict the probability of Beta Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Bionics' price. Additionally, you may evaluate how the addition of Beta Bionics to your portfolios can decrease your overall portfolio volatility.